Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasminogen-like protein B is a secreted plasma protein encoded by the PLGLB1 gene. It exhibits similarity to the N-terminal activation peptide of plasminogen and can bind lysine residues on plasminogen's kringle domains, potentially modulating plasminogen activity and extracellular matrix remodeling. Expression of PLGLB1 is variable between tissues and is upregulated in some cancers. Its clinical role is unclear, and there are no drugs that directly interact with this target. The protein is not considered an enzyme, receptor, or transporter, but is grouped among plasma proteins with structural homology to plasminogen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasminogen-like protein B (PLGLB1).